BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23386604)

  • 21. Crystal structure of the human angiotensin II type 2 receptor bound to an angiotensin II analog.
    Asada H; Horita S; Hirata K; Shiroishi M; Shiimura Y; Iwanari H; Hamakubo T; Shimamura T; Nomura N; Kusano-Arai O; Uemura T; Suno C; Kobayashi T; Iwata S
    Nat Struct Mol Biol; 2018 Jul; 25(7):570-576. PubMed ID: 29967536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
    Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
    J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of transmembrane domains 1 and 4 of the human angiotensin II AT1 receptor by cysteine-scanning mutagenesis.
    Yan L; Holleran BJ; Lavigne P; Escher E; Guillemette G; Leduc R
    J Biol Chem; 2010 Jan; 285(4):2284-93. PubMed ID: 19940150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis.
    Martin SS; Boucard AA; Clément M; Escher E; Leduc R; Guillemette G
    J Biol Chem; 2004 Dec; 279(49):51415-23. PubMed ID: 15452107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational approaches on angiotensin receptors and their ligands: recent developments and results.
    Tuccinardi T; Martinelli A
    Curr Med Chem; 2007; 14(29):3105-21. PubMed ID: 18220745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of an agonistic, difluoro-azido photolabel of angiotensin II and labeling of the AT1 receptor: transmembrane domains 3, 6, and 7 form the ligand-binding pocket.
    Gagnon T; Fillion D; Lefebvre MR; Escher E
    J Recept Signal Transduct Res; 2006; 26(5-6):435-51. PubMed ID: 17118791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR.
    Wingler LM; Skiba MA; McMahon C; Staus DP; Kleinhenz ALW; Suomivuori CM; Latorraca NR; Dror RO; Lefkowitz RJ; Kruse AC
    Science; 2020 Feb; 367(6480):888-892. PubMed ID: 32079768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temperature dependent photolabeling of the human angiotensin II type 1 receptor reveals insights into its conformational landscape and its activation mechanism.
    Arsenault J; Cabana J; Fillion D; Leduc R; Guillemette G; Lavigne P; Escher E
    Biochem Pharmacol; 2010 Oct; 80(7):990-9. PubMed ID: 20599798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the Cys18-Cys274 disulfide bond and of the third extracellular loop in the constitutive activation and internalization of angiotensin II type 1 receptor.
    Correa SA; Pignatari GC; Ferro ES; Pacheco NA; Costa-Neto CM; Pesquero JB; Oliveira L; Paiva AC; Shimuta SI
    Regul Pept; 2006 May; 134(2-3):132-40. PubMed ID: 16626818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.
    Domazet I; Holleran BJ; Martin SS; Lavigne P; Leduc R; Escher E; Guillemette G
    J Biol Chem; 2009 May; 284(18):11922-9. PubMed ID: 19276075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor.
    Zhang H; Unal H; Desnoyer R; Han GW; Patel N; Katritch V; Karnik SS; Cherezov V; Stevens RC
    J Biol Chem; 2015 Dec; 290(49):29127-39. PubMed ID: 26420482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dependence of agonist activation on a conserved apolar residue in the third intracellular loop of the AT1 angiotensin receptor.
    Hunyady L; Zhang M; Jagadeesh G; Bor M; Balla T; Catt KJ
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10040-5. PubMed ID: 8816747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor.
    Perlman S; Schambye HT; Rivero RA; Greenlee WJ; Hjorth SA; Schwartz TW
    J Biol Chem; 1995 Jan; 270(4):1493-6. PubMed ID: 7829475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for transmembrane domains V and VI in ligand binding and maturation of the angiotensin II AT1 receptor.
    Pignatari GC; Rozenfeld R; Ferro ES; Oliveira L; Paiva AC; Devi LA
    Biol Chem; 2006 Mar; 387(3):269-76. PubMed ID: 16542148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning of a ferret angiotensin II AT(1) receptor reveals the importance of position 163 for Losartan binding.
    Gosselin MJ; Leclerc PC; Auger-Messier M; Guillemette G; Escher E; Leduc R
    Biochim Biophys Acta; 2000 Jun; 1497(1):94-102. PubMed ID: 10838163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants.
    Monnot C; Bihoreau C; Conchon S; Curnow KM; Corvol P; Clauser E
    J Biol Chem; 1996 Jan; 271(3):1507-13. PubMed ID: 8576145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Structure and functions of the angiotensin II AT1 receptors during evolution].
    Auzan C; Clauser E
    J Soc Biol; 2009; 203(4):295-302. PubMed ID: 20122387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation of a conserved fifth transmembrane domain lysine residue (Lys215) attenuates ligand binding in the angiotensin II type 2 receptor.
    Yee DK; Kisley LR; Heerding JN; Fluharty SJ
    Brain Res Mol Brain Res; 1997 Nov; 51(1-2):238-41. PubMed ID: 9427526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis of the angiotensin II type 2 receptor: contribution of conserved extracellular amino acids.
    Heerding JN; Yee DK; Jacobs SL; Fluharty SJ
    Regul Pept; 1997 Oct; 72(2-3):97-103. PubMed ID: 9652982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.